Occudo Quantitative Strategies LP Gt Biopharma, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $56.1 $6,275 - $194,498	-3,467 Reduced 16.51%	17,536 $31,000
Q2 2022 Aug 15, 2022	BUY	$1.64 - $3.11 $1,521 - $2,886	928 Added 4.62%	21,003 $63,000
Q1 2022 May 16, 2022	SELL	$2.6 - $3.3 $7,880 - $10,002	-3,031 Reduced 13.12%	20,075 $58,000
Q4 2021 Feb 14, 2022	BUY	$3.05 - $7.08 $70,473 - $163,590	23,106 New	23,106 $70,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.